As a company, we delivered GAAP earnings per share of $0.95, $0.83 on an adjusted basis on $232 million in revenue, an increase of nearly 10% from Q3 last year.
After making these non-GAAP adjustments, adjusted earnings per share was $0.83 this quarter compared to $0.96 last year.
Adjusted earnings per share of between $3.15 and $3.30 increased from prior guidance of $2.19 to $3.20 and adjusted EBITDA of between $230 million and $240 million increased from prior guidance of $225 million to $240 million.
GAAP earnings per share of between $3.23 and $3.38 increased from prior guidance of $2.84 to $3.14.
As a company, we delivered GAAP earnings per share of $0.95, $0.83 on an adjusted basis on $232 million in revenue, an increase of nearly 10% from Q3 last year.
After making these non-GAAP adjustments, adjusted earnings per share was $0.83 this quarter compared to $0.96 last year.
As a company, we delivered GAAP earnings per share of $0.95, $0.83 on an adjusted basis on $232 million in revenue, an increase of nearly 10% from Q3 last year.
Earnings per share were $0.95 in this quarter compared to $0.92 last year.
We are also updating our previously issued guidance ranges for company-level performance, including revenue of between $900 million and $920 million increased from prior guidance of $880 million to $910 million.
For the third quarter, total company net sales were $232.4 million, an increase of 9.6% compared to the $212 million delivered in the same quarter last year. As a company, we delivered GAAP earnings per share of $0.95, $0.83 on an adjusted basis on $232 million in revenue, an increase of nearly 10% from Q3 last year.
Adding to these options, Albany's Board of Directors has authorized a $200 million share repurchase program, expanding the set of capital allocation alternatives we have at our disposal.
However, given our modest leverage and strong free cash flow outlook, the Board of Directors has authorized a $200 million share repurchase program.
This time may be different, as we don't see inflationary pressures abating anytime soon.
Capital expenditures in the range of $40 million to $50 million also unchanged from prior guidance.
